Chrome 2001
.
Aetna Intelihealth InteliHealth Aetna Intelihealth Aetna Intelihealth
 
.
. .
.
Chrome 2001
Chrome 2001
Health News Health News
.
Health Highlights: March 21, 2014
March 21, 2014

 

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Infant Cot Canopies Recalled by Ikea
Ikea is recalling millions of infant cot canopies that pose a strangulation risk.
The move comes after customer complained that canopy nets were being pulled into cots and getting tangled around infants' necks. The Swedish furniture retailer says it is not aware of any reports of "permanent injury," the Associated Press reported.
The recall covers canopies used to cover cots in the following models: Legendarisk, Minnen bed canopy set, Barnslig Boll, Minnen Brodyr, Himmel, Fabler, Tissla and Klammig. Ikea has sold about 2.7 million canopies worldwide since 1996.
The company said it would give customers full refunds when they returned the canopies to the retailer, the AP reported.

-----
Stress-Linked Protein May Play Major Role in Alzheimer's
A problem in the brain's stress response system may be an important factor in the memory and thinking problems experienced by people with Alzheimer's disease and other dementias, new research says.
Harvard scientists found that when the system is working normally, it can protect the brain from Alzheimer's-related proteins. But if it malfunctions, important areas of the brain begin to deteriorate, The New York Times reported.
Specifically, a protein called REST helps protect brain cells in healthy seniors from aging-related stresses, but levels of the protein are much lower in important brain regions in people with Alzheimer's and other dementias.
The protein could offer a target for the development of new drugs for dementias, The Times reported.
The findings were published Wednesday in the journal Nature.
"This is an extremely important study," Li-Huei Tsai, director of the Picower Institute for Learning and Memory at the Massachusetts Institute of Technology, told The Times.
"This is the first study that is really starting to provide a plausible pathway to explain why some people are more vulnerable to Alzheimer's than other people," said Tsai, who was not involved in the study but wrote an accompanying commentary.
Further studies are needed to determine if lower REST levels are caused by or the result of brain degeneration in Alzheimer's patients or whether focusing on the protein could lead to effective treatments.
"You're going to see a lot of papers now following up on it," Dr. Eric Reiman, executive director of the Banner Alzheimer's Institute in Phoenix, told The Times.
"While it's a preliminary finding, it raises an avenue that hasn't been considered before. And if this provides a handle on which to understand normal brain aging, that will be great, too," said Reiman, who was not involved in the research.Copyright © 2014 HealthDay. All rights reserved.


...

InteliHealth
.
.
.
.
.
More News
InteliHealth .
.
General Health News
Today's News
Today In Health History
This Week In Health
Addiction News
Allergy News
Alzheimer's News
Arthritis News
Asthma News
Babies News
Breast Cancer News
Bronchitis News
Cancer News
Cervical Cancer News
Children's Health News
Cholesterol News
Dental/Oral Health News
Depression News
Diabetes News
Ear, Nose And Throat News
Environmental Health News
Eye News
Fitness News
Genetics News
Headache News
Health Policy News
Heart Attack News
Heart Failure News
Heart Health News
HIV/AIDS News
Infectious Diseases News
Influenza News
Lung Cancer News
Medication News
Men's Health News
Mental Health News
Multiple Sclerosis News
Nutrition News
Parkinson's News
Pregnancy News
Prostate Cancer News
Schizophrenia
Senior Health News
Sexual/Reproductive Health News
Sexual dysfunction
Sleep News
STDs News
Stroke News
Tobacco Cessation News
Weight Management News
Women's Health News
.
.
.
.
InteliHealth
    Print Printer-friendly format    
   
.  
This website is certified by Health On the Net Foundation. Click to verify.
.